In The News

The Biden administration has selected a Dana-Farber Brigham Cancer Center surgeon and professor at Harvard Medical School as the next director of the National Cancer

WASHINGTON — The Biden administration has selected Monica Bertagnolli, a renowned surgical oncologist, as the next director of the National Cancer Institute, according to two

Harvard cancer surgeon Monica M. Bertagnolli is on tap to serve as the next director of the National Cancer Institute, indicating the White House plans

President Joe Biden is expected to pick cancer surgeon Monica Bertagnolli as the next director of the National Cancer Institute (NCI). Bertagnolli, a physician-scientist at

President Joe Biden is expected to name Bertagnolli, who is now chief of the Division of Surgical Oncology at Brigham and Women’s Hospital and Dana-Farber

Lori J. Pierce, MD, FASTRO, FASCO, started her session with “the obvious.” The chair of the American Society of Clinical Oncology (ASCO) Board of Directors

Randall A. Oyer, MD, medical director of the Ann B. Barshinger Cancer Institute, medical director of oncology, and medical director of the Cancer Risk Evaluation

Without directly referencing Biogen, Inc.’s Alzheimer’s drug Aduhelm (aducanumab-avwa), the leader of the US Food and Drug Administration’s drugs center defended the agency’s ability to make

NEW YORK – Drugmakers, academic oncologists, and even regulators are becoming more accepting of clinical trials using synthetic, or external, control arms when evaluating the

When it comes to biomarker and surrogate endpoint development, the US Food and Drug Administration has a plea for industry: “think early.” Work on establishing